Logopharm GmbH

Logopharm GmbH is a research-oriented biotechnology company based in Freiburg, Germany. Founded in 2005 by a team of leading scientists and business experts, the company develops advanced proteomic technologies and tools to provide cutting-edge research and development solutions to the pharmaceutical and biotech industry as well as to academic institutions. Logopharm specializes in the analysis of challenging targets such as ion channels, G protein-coupled receptors, and other membrane proteins and protein complexes from native sources. The company combines proprietary proteomic technologies, long-term experience in functional membrane protein analysis, and innovative drug development concepts, with a focus on membrane proteins and protein complexes. Based on this foundation, Logopharm conducts independent research and offers tools, specialized services, as well as research consulting and technology implementation, individually adapted to customer needs. Its approaches are based on native source material (close to physiology) and are applicable to all types of proteins, especially membrane proteins, protein complexes, and low-abundance proteins. Logopharm has developed and uses proprietary technology and know-how in crucial areas including membrane protein solubilisation and fractionation, affinity purification, micro-proteomic analysis, and mass spectrometry (including quantification). Its internal database comprises more than 1,000 membrane protein target purifications, representing a unique resource. The company offers products such as ComplexioLyte buffers (a set of standardized detergent buffers for efficient extraction of native protein complexes from biological membranes) and antibodies directed against membrane proteins or associated interaction partners, which are extensively validated using native target specimens, knockout controls, and mass spectrometry. It also provides highly sensitive and robust LC-MS/MS analysis services. Logopharm operates from two locations in Germany: a laboratory and shipping facility at Hermann-Herder-Str. 7, 79104 Freiburg, and an administration office at Schlossstr. 14, 79232 March. The company considers strategic partnerships an essential part of its business strategy and has established collaborations with distinguished expert laboratories, including the Institute of Physiology II at the University of Freiburg, the Division of Molecular and Cellular Pharmacology at the Medical University of Innsbruck, the Center of Neuroscience at the University of California, Davis, the Max-Planck-Institute for Biochemistry in Martinsried, and the Institute of Biochemistry and Biophysics at the University of Jena. It is a member of networks such as CTO (Campus Technologies Oberrhein), Biovalley Deutschland, and BIO (Biotechnology Industry Organization).

Logopharm GmbH was founded in 2005 in Freiburg, Germany, by a team of leading scientists and business experts. The company was established as a research-oriented biotech firm focused on providing advanced solutions in proteomic target and biomarker research and development. From its inception, Logopharm concentrated on the analysis of challenging membrane proteins, ion channels, G protein-coupled receptors, and protein complexes from native sources. Over the years, Logopharm developed proprietary technologies and know-how in membrane protein solubilisation and fractionation, affinity purification, micro-proteomic analysis, and mass spectrometry. A key asset is its internal database, which now comprises more than 1,000 membrane protein target purifications. The company translated its research into commercial products and services, including the ComplexioLyte line of standardized detergent buffers for extracting native protein complexes, a range of extensively validated antibodies against membrane proteins, and LC-MS/MS-based proteomic analysis services. Logopharm has pursued a strategy of strategic partnerships and academic collaborations. It has worked with the Institute of Physiology II at the University of Freiburg on functional proteomics of ion channel complexes, the Division of Molecular and Cellular Pharmacology at the Medical University of Innsbruck on antibody generation and binding assays, the Center of Neuroscience at the University of California, Davis on antibody validation, the Max-Planck-Institute for Biochemistry in Martinsried on mass spectrometry technology, and the Institute of Biochemistry and Biophysics at the University of Jena on functional characterization of NaV channel targets. The company is also a member of industry networks including CTO (Campus Technologies Oberrhein), Biovalley Deutschland, and BIO (Biotechnology Industry Organization). In recent years, Logopharm has announced the launch of antibody products and initiated software development for mass spectrometry, signaling continued expansion of its product and technology portfolio. The company remains privately held and operates from Freiburg and March, Germany.

• 2005

  Logopharm GmbH founded in Freiburg, Germany by a team of leading scientists and business experts.

• Logopharm announces launch of antibody products.

• Logopharm initiates software development for mass spectrometry.

Research-oriented biotech company providing advanced proteomic solutions for challenging membrane protein targets, combining proprietary technologies with native-source analysis.

• ComplexioLyte Buffers

  A set of standardized detergent buffers for efficient extraction of native protein complexes from biological membranes in different applications. Ready-to-use buffers can be directly purchased; optimization services are also offered.

• Antibodies

  Antibodies directed against membrane proteins or associated interaction partners, extensively validated for each application using native target specimens, knockout controls and mass spectrometry.

• Mass Spectrometry Services

  Highly sensitive and robust LC-MS/MS analysis combined with identification of post-translational modifications or quantification for comprehensive proteomic analysis of cell lines, tissues or affinity-purified proteins and protein complexes.

• R&D Services

  Specialized services, research consulting and implementation of technology, individually adapted to customer needs.

1. 1Logopharm - Services for the Pharma and Biotech Industrylogopharm.com
2. 2Logopharm - About uslogopharm.com
3. 3Logopharm - Products & Serviceslogopharm.com
4. 4Logopharm - Partnerslogopharm.com
5. 5Logopharm (Germany) - Wikidatawikidata.org